Ellen Rosenberg Net Worth & Insider Trades
Ellen Rosenberg - Chief Legal Officer, Amicus Therapeutics, Inc
What is Ellen Rosenberg's Net Worth?
The current estimated net worth of Amicus Therapeutics, Inc's Chief Legal Officer, Ellen Rosenberg, is estimated to be about $3.99M . Ellen Rosenberg owns about 347,345 units of Amicus Therapeutics, Inc common stock. In the last 7 years at Amicus Therapeutics, Inc, Ellen Rosenberg has sold an estimated value of $3.82M worth.
What is Ellen Rosenberg's Past Insider Trading?
Ellen Rosenberg's largest purchase order was 30,000 units , worth over $154.8K on July 20, 2020. Ellen Rosenberg's largest sale order was 30,000 units , worth over $457.91K on July 20, 2020. In total, Ellen Rosenberg has made about 27 transactions over 7 years of their time at Amicus Therapeutics, Inc. Ellen Rosenberg usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 31,839 units , worth over $424.01K on January 25, 2023.
Ellen Rosenberg
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Ellen Rosenberg's Salary in 2020?
As Chief Legal Officer of Amicus Therapeutics, Inc, Ellen Rosenberg has a total base salary of $452, . Ellen Rosenberg received compensation valued at about $2,885,820 in 2020 after becoming Chief Legal Officer. The vast majority of their compensation came in the form of a bonus of $199,051 , stock awards of $1,461,322 , other earnings, plans or compensations of $664,660 , change in pension value of $87,751 , and other compensation of $20,748 .
What is Ellen Rosenberg's' Mailing Address?
- Mailing address is C/o Amicus Therapeutics 1 Cedar Brook Drive Cranbury NJ 08560 NJ
Amicus Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John F. Crowley | 2020 | $719,514 | $514,800 | $5,479,971 | $2,492,491 | $1,282,843 | $825,505 | $11,315,124 |
| John F. Crowley | 2019 | $656,770 | $476,815 | $5,327,948 | $2,334,850 | $234,775 | $821,505 | $9,852,663 |
| John F. Crowley | 2018 | $637,640 | $445,710 | $3,861,699 | $1,654,347 | - | $820,567 | $7,419,963 |
| Daphne Quimi | 2020 | $45 | $228,712 | $1,534,382 | $697,894 | - | $34,639 | $2,947, |
| Daphne Quimi | 2019 | $400,000 | $212,960 | $1,311,492 | $538,808 | - | $17,487 | $2,480,747 |
| Daphne Quimi | 2018 | - | - | - | - | - | - | - |
| Bradley L. Campbell | 2020 | $515, | $368,872 | $2,557,304 | $1,163,159 | - | $33,694 | $4, |
| Bradley L. Campbell | 2019 | $500,877 | $378,788 | $2,254,114 | $987,822 | - | $19,538 | $4,141,139 |
| Bradley L. Campbell | 2018 | $468,109 | $327,209 | $1,411,802 | $604,817 | - | $16,710 | $2,828,646 |
| Hung Do | 2020 | $42 | $187,908 | $1,461,322 | $664,660 | - | $31,248 | $2,772,106 |
| Hung Do | 2019 | $414,625 | $200,678 | $1,393,462 | $574,732 | - | $22,129 | $2,605,626 |
| Hung Do | 2018 | - | - | - | - | - | - | - |
| Ellen S. Rosenberg | 2020 | $452, | $199,051 | $1,461,322 | $664,660 | $87,751 | $20,748 | $2,885,820 |
| Ellen S. Rosenberg | 2019 | $439,213 | $233,837 | $1,393,462 | $610,648 | - | $13,538 | $2,690,698 |
| Ellen S. Rosenberg | 2018 | $426,420 | $208,647 | $996,591 | $426,933 | - | $18,270 | $2,076,862 |
| Jay Barth | 2020 | $366,269 | - | $1,315,184 | $598,197 | - | $641,306 | $2,920,956 |
| Jay Barth | 2019 | $471,621 | $228,265 | $1,229,522 | $538,808 | - | $15,998 | $2,484,214 |
| Jay Barth | 2018 | $457,885 | $192,037 | $996,591 | $426,933 | - | $18,790 | $2,092,236 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm
What are Amicus Therapeutics, Inc's Past Insider Trades?
Amicus Therapeutics, Inc's most recent insider trade came on January 25, 2023 by Ellen Rosenberg who sold 31,839 units worth $424.01K . In the last 16 years, insiders at Amicus Therapeutics, Inc have sold an estimated value of $183.87M and bought an estimated value of $192.24M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman, Bradley Campbell, President & CEO, and Daphne Quimi, Chief Financial Officer .
AMICUS THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||